| CNS | Central nervous system |
| AEM | Autoimmune ecncephalomyelitis |
| CSF | Cerebrospinal fluid |
| AQP4 | Aquaporin 4 |
| PNS | Paraneoplastic neurological syndrome |
| HLA | Human leukocyte antigen |
| PERM | Progressive encephalomyelitis with rigidity and myoclonus |
| SCLC | Small cell lung cancer |
| GAD | Glutamic acid decarboxylase |
| GlyR | Glycine receptor |
| VGKC | Voltage-gated potassium channel |
| NMDAR | N-methyl-D-aspafrtate receptor |
| CTL | Cytotoxic T lymphocyte |
| CRMP5 | Collapsing response mediator protein 5 |
| DNER | Delta/notch-like epidermal growth factor-related receptor |
| Ab | antibody-mediated disturbance of receptor/channel function |
| AMPAR | α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic receptor |
| LGI1 | leucine-rich glioma inactivated 1 |
| CASPR2 | contactine-associated protein-like 2 |
| GABABR | γ-aminobutyric acid type B receptor |
| GABAAR | γ-aminobutyric acid type A receptor |
| VGCC | voltage-gated calcium channel |
| LEMS | Lambert-Eaton myasthenic syndrome |
| mGluR1/5 | metabotropic glutamate receptor 1/5 |